Ryan Henrie

ORCID: 0000-0002-8868-3453
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Viral-associated cancers and disorders
  • Chronic Myeloid Leukemia Treatments
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • CNS Lymphoma Diagnosis and Treatment
  • Blood groups and transfusion
  • Histiocytic Disorders and Treatments
  • Cutaneous lymphoproliferative disorders research
  • Lymphoma Diagnosis and Treatment
  • Kruppel-like factors research
  • Autoimmune and Inflammatory Disorders Research
  • Renal Diseases and Glomerulopathies
  • Fungal Infections and Studies
  • Complement system in diseases

St. Paul's Hospital
2020-2024

University of British Columbia
2020-2024

Royal Columbian Hospital
2023

Prior studies have suggested that immune thrombotic thrombocytopenic purpura (iTTP) may display seasonal variation; however, methodologic limitations and sample sizes diminished the ability to perform a rigorous assessment. This 5-year retrospective study assessed epidemiology of iTTP determined whether it displays pattern. Patients with both initial relapsed (defined as disintegrin metalloprotease thrombospondin type motifs 13 activity <10%) from 24 tertiary centers in Australia, Canada,...

10.1002/ajh.27458 article EN cc-by American Journal of Hematology 2024-08-13

Abstract Allogeneic hematopoietic cell transplantation (HCT) is the only curative therapy for myelofibrosis (MF) and recommended patients with higher risk disease. However, there a of early mortality, optimal timing unknown. JAK inhibitor (JAKi) may offer durable improvement in symptoms, splenomegaly quality life. The aim this multicentre, retrospective observational study was to compare outcomes aged 70 years or below MF chronic phase who received upfront JAKi vs. HCT dynamic international...

10.1038/s41409-023-02146-6 article EN cc-by Bone Marrow Transplantation 2023-11-08

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an aggressive hematologic malignancy which associated with a distinctive morphologic appearance. However, the morphology not specific, and diagnostic characterization requires integration of immunophenotypic genetic testing. We herein report case 35-year-old female patient who presented worsening cytopenia. A bone marrow aspirate identified medium-sized blastic cells perinuclear microvacuoles (“pearl neckless”). Occasional blasts...

10.1155/2023/5014728 article EN cc-by Case Reports in Hematology 2023-11-01
Coming Soon ...